Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine.
The feasibility of using "clustered charge-to-alanine" mutagenesis (replacement by alanine of two or more charged residues clustered in a five- or six-amino acid sequence) to create temperature-sensitive, conditionally lethal mutations in vaccinia virus was examined by creating nine mutations in the vaccinia virus gene G2R. G2R was chosen for this analysis because mutations in this gene confer selectable phenotypes. Specifically, vaccinia viruses that contain a wild-type copy of G2R nare sensitive the effects of the anti-poxvirus drug isatin-beta-thiosemicarbazone (IBT), while mutations in G2R that completely abolish the function of the G2R protein product confer dependence upon IBT for growth. A previously isolated mutant carrying a temperature-sensitive mutation that maps to G2R (Cts56) is resistant to IBT at the permissive temperature and dependent upon IBT at the restrictive temperature. Nine clustered charge-to-alanine mutants were examined. Four of the these mutants (AS1, AS4, AS6, and AS9) display some degree of temperature sensitivity in the function of the G2R gene product. AS1 is temperature sensitive for growth in both a plaque assay and in a one-step growth experiment. AS6 and AS9 form small plaques at the nonpermissive temperature and are temperature sensitive for growth in a one-step growth experiment. AS4 manifests its temperature sensitivity as temperature-dependent IBT resistance. Five of the mutations (AS2, AS3, AS5, AS7, and AS8) appeared to confer phenotypes indistinguishable from that of wild-type vaccinia. These results demonstrate that temperature-sensitive conditionally lethal mutants can be created in vaccinia virus by altering the charge characteristics of essential viral proteins.
Hassett
D E
DE
Department of Immunology and Medical Microbiology, University of Florida, Gainesville 32610-0266.
Condit
R C
RC
D000409:Alanine; D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D005799:Genes, Dominant; D005814:Genes, Viral; D007510:Isatin / Q000031:analogs & derivatives / Q000633:toxicity; D007700:Kinetics; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009154:Mutation; D010641:Phenotype; D013696:Temperature; D013997:Time Factors; D014616:Vaccinia virus / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D010948:Viral Plaque Assay; D014764:Viral Proteins / Q000096:biosynthesis / Q000235:genetics*
C087272:G2R protein, Vaccinia virus; D014764:Viral Proteins; C013578:isatin beta-thiosemicarbazone; D007510:Isatin; D000409:Alanine